Expression of full-length utrophin prevents muscular dystrophy in mdx mice
- PMID: 9846586
- DOI: 10.1038/4033
Expression of full-length utrophin prevents muscular dystrophy in mdx mice
Abstract
Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fiber leading to the gradual depletion of skeletal muscle. The molecular structure of dystrophin is very similar to that of the related protein utrophin. Utrophin is found in all tissues and is confined to the neuromuscular and myotendinous junctions in mature muscle. Sarcolemmal localization of a truncated utrophin transgene in the dystrophin-deficient mdx mouse significantly improves the dystrophic muscle phenotype. Therefore, up-regulation of utrophin by drug therapy is a plausible therapeutic approach in the treatment of DMD. Here we demonstrate that expression of full-length utrophin in mdx mice prevents the development of muscular dystrophy. We assessed muscle morphology, fiber regeneration and mechanical properties (force development and resistance to stretch) of mdx and transgenic mdx skeletal and diaphragm muscle. The utrophin levels required in muscle are significantly less than the normal endogenous utrophin levels seen in lung and kidney, and we provide evidence that the pathology depends on the amount of utrophin expression. These results also have important implications for DMD therapies in which utrophin replacement is achieved by delivery using exogenous vectors.
Similar articles
-
Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.Nat Genet. 1998 May;19(1):79-82. doi: 10.1038/ng0598-79. Nat Genet. 1998. PMID: 9590295
-
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.Nature. 1996 Nov 28;384(6607):349-53. doi: 10.1038/384349a0. Nature. 1996. PMID: 8934518
-
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.Gene Ther. 2003 May;10(9):750-7. doi: 10.1038/sj.gt.3301941. Gene Ther. 2003. PMID: 12704413
-
[Utrophin, a way to cure Duchenne muscle dystrophy].Med Sci (Paris). 2004 Apr;20(4):442-7. doi: 10.1051/medsci/2004204442. Med Sci (Paris). 2004. PMID: 15124117 Review. French.
-
An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.Acta Neurol Belg. 2000 Sep;100(3):146-50. Acta Neurol Belg. 2000. PMID: 11098286 Review.
Cited by
-
Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse.PLoS One. 2012;7(1):e30063. doi: 10.1371/journal.pone.0030063. Epub 2012 Jan 11. PLoS One. 2012. PMID: 22253880 Free PMC article.
-
High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy.Skelet Muscle. 2020 Sep 18;10(1):26. doi: 10.1186/s13395-020-00244-3. Skelet Muscle. 2020. PMID: 32948250 Free PMC article.
-
Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice.Am J Pathol. 2004 Feb;164(2):711-8. doi: 10.1016/S0002-9440(10)63158-6. Am J Pathol. 2004. PMID: 14742274 Free PMC article.
-
Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan.J Cell Biol. 2007 Mar 26;176(7):965-77. doi: 10.1083/jcb.200604179. J Cell Biol. 2007. PMID: 17389230 Free PMC article.
-
Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle.Hum Mol Genet. 2019 Apr 1;28(7):1117-1135. doi: 10.1093/hmg/ddy418. Hum Mol Genet. 2019. PMID: 30535187 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
